The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: A Phase I trial in Taiwan
- 1 December 2013
- journal article
- research article
- Published by Elsevier BV in Journal of Microbiology, Immunology and Infection
- Vol. 46 (6), 448-455
- https://doi.org/10.1016/j.jmii.2012.08.002
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbitsVaccine, 2011
- Trivalent MDCK cell culture-derived influenza vaccine Optaflu®(Novartis Vaccines)Expert Review of Vaccines, 2009
- Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trialsVaccine, 2009
- Immunogenicity, Safety, and Cross‐Reactivity of an Inactivated, Adjuvanted, Prototype Pandemic Influenza (H5N1) Vaccine: A Phase II, Double‐Blind, Randomized TrialClinical Infectious Diseases, 2009
- Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adultsVaccine, 2009
- Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccinesVaccine, 2008
- Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in AdultsThe Journal of Infectious Diseases, 2008
- Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaThe Lancet, 2001
- Replication of avian influenza viruses in humansArchiv für die gesamte Virusforschung, 1991
- Serological evidence of human infections with avian influenza virusesArchiv für die gesamte Virusforschung, 1986